Topic: Biotechnology Sector

Will Wyeth Revolutionize Research at Pfizer?

Last fall, when we visited Wyeth Biotech's campus in Andover, MA, we were blown away by the management's off-the-beaten-path approach to drug development and innovation. Now the storyline has hit an unexpected twist: Officials at ...READ»

Wyeth's Multibillion-dollar Biotech Bet

Drugmaker Wyeth bet billions on biotech, transforming its culture and boosting profits.READ»

Drug Companies Love Profits

It's not too surprising that drug companies love profit and focus on staying in business by creating and marketing new drugs. READ»

A Dose of Change

Face time with Kevin Sharer.READ»

Genzyme at CGI: Global Problem-Solving Gives You a Competitive Advantage

If your corporate social responsibility (CSR) program is ancillary to your corporate strategy, it's on the chopping block--or already in the waste bin. This is especially true in today's economy. On the flip side, you have a chance to ...READ»

Can Protein Sciences Produce a Swine Flu Vaccine in Time? Update: Likely No

As the start of a new school year begins, concerns over H1N1--aka swine flu--are growing. Everyone's waiting to hear when a vaccine will be available, and earlier this summer, the CDC predicted that 120 million doses ... READ»

GENERIC: How generate image brand distinction in a world where all have the same name?

                                                                                                        Read listening Mozart  ...READ»

Why Vaccine Makers Can't Keep Up with the H1N1 Virus

There isn't enough H1N1 vaccine to go around, which is why President Barack Obama declared the outbreak a national emergency over the weekend. Why can't we produce H1N1 vaccines fast enough? Because of chicken eggs.READ»

Blowing the Whistle for the IRS

Most people would just love to get money from the IRS, and not just their regular tax refund, but instead a major chunk of change that would set them up for life.READ»

Brilliant Biotech

Our Innovation Scorecard takes a look at one of the hottest industries around, and comes up with four companies to watch.READ»

Update

Take Two From big molecules spring big deals: Drugmaker Wyeth, which develops large-molecule pharmaceuticals cultivated from living cells ("Grand Experiment," February), is set to be acquired by Pfizer in a $68 billion ...READ»

• Feedback

Drug Flow and Deal Flow

Biotech Investing Conference November 5-6 Menlo Park, California The news at this year's Biotech Investing confab will focus on Big Pharma companies, as they take a more active role in developing early-stage drugs. ...READ»

Digital Matters - Issue 29

In My Humble Opinion: Genomics is the most important economic, political, and ethical issue facing mankind.READ»

Defective Drugs Take Their Toll

Anyone who has been made sick by taking a drug with ghastly side effects knows full well they can take their deadly toll. READ»

No Time to Network

No matter how often we pledge to dedicate more time to develop more meaningful relationships with colleagues and partners, we're still as busy as ever. So how can we build more relationships, when we already have so many things ...READ»

Heartburn

If you want an edifying look at how the drug business in this country works, you'd do well to read the article in today's New York Times (registration req'd) about the shortage of Prilosec OTC, the heartburn medication made by Astra ...READ»

Criminals Who Manufacture Drugs Are Entitled to Defense

There are times in a person's life when the call of millions of dollars is far too strong to resist. Those who choose to manufacture drugs to obtain those millions are still entitled to the finest criminal defense possible.READ»

Generic Drugs Keep Health Insurance Prices Low

For those wanting to keep their health insurance expenses down, generic drugs are the answer. READ»

CEO See-Ya!

Raymond Gilmartin, CEO of Merck Co.READ»

$5M to Make NYC a Hub for Biotech Startups

San Francisco, Los Angeles, and San Diego are often referred to as the major U.S. biotech hubs. New York City, no longer content to remain king of media and finance, is determined to join the club. To that end, the NYCIF, Henry ...READ»

Not Invented Here

The next blockbuster drug could come from anywhere. It's up to Merck's scouts to find it.READ»

The Biology of Business

The old model: Companies live forever and the people die. The new model:READ»

Heal Thyself

Recruiter Cheryl Buxton helps us navigate the meritocratic, objective health-care job market.READ»

Lilly's R<amp></amp>D Prescription

How does pharmaceutical giant Eli Lilly accelerate the pace while reducing the cost of innovation? By corralling scientists around the world in a Web-based system of eRD.READ»

MBAs Rate the Recruiters

Some B-school rankings ask corporate recruiters to rate the top MBA programs. But the MBAs at Stanford Business School decided to turn the tables on that idea by recognizing the top recruiters. The winners: PepsiCo, Boston ...READ»